StockData

Akso Health vs Callan JMB

AHG and CJMB side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AHG and CJMB compare

Akso Health grew revenue faster over the last twelve months (−6.4% versus −13.8% for Callan JMB).

Akso Health keeps more of each dollar of sales as profit, with a net margin of −135% compared with −192% at Callan JMB.

Callan JMB scores higher on the StockData Score (8 against 7 for Akso Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAHGCJMB
Size and price
Market cap–$2.3M
Share price$1.24$0.408
Change, 1 year−17.9%−89.2%
Change, 5 years−57.7%–
Beta (5Y)0.530.32
Employees1220
StockData Score
Total score78 (better)
Valuation score02 (better)
Growth score11
Performance score1 (better)0
Health score55
Dividend score00
Valuation
P/S–0.5×
P/B–3.4×
FCF yield–−202%
Fair value–$1.79
Margin of safety–77.2%
Growth
Revenue growth (TTM)−6.4% (better)−13.8%
Revenue growth, 5Y average51.1%–
EPS growth (TTM)−93.8%–
Profitability
Gross margin−0.08%39.9% (better)
Operating margin−150%−146% (better)
Net margin−135% (better)−192%
FCF margin−92.5% (better)−93.1%
Return on equity−9.8% (better)−300%
Return on invested capital−16.1% (better)−826%
Financial health
Debt / equity0.000.00
Current ratio21.77 (better)1.30
Altman Z-score–−8.51
Piotroski F-score5 (better)3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions0.01%10.8%
Held by insiders0.00%68.5%
Insider net buying, 12 months–$165K
Short interest, % of float–11.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.